Literature DB >> 24653811

Bacterial isolates associated with pelvic inflammatory disease among female patients attending some hospitals in abuja, Nigeria.

T H I Spencer1, P O Umeh2, E Irokanulo3, M M Baba4, B B Spencer5, A I Umar1, S A Ardzard3, S Oderinde4, O Onoja3.   

Abstract

BACKGROUND: Pelvic inflammatory disease refers to any infection in the female lower reproductive tract that spreads to the upper reproductive tract. The disease comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess and pelvic peritonitis. PID is not a notifiable disease in most countries, so accurate statistics are not available. This situation is not in any way different here in Nigeria and more so in the Federal Capital Territory, Abuja where this research was conducted, there had never been any published report so far on PID. It therefore became pertinent that such studies be carried out to evaluate the bacterial organisms which may be associated with the disease in this part of Nigeria so that health care providers could take a better look at this affliction in women.
MATERIALS AND METHODS: Endocervical swabs totalling 100 were aseptically collected from patients with confirmed Pelvic Inflammatory Disease (PID), attending some hospitals in Abuja, Nigeria for detection of bacterial pathogens based on cultural and biochemical characterisation tests. Antibiogram was also conducted on the identified bacterial isolates.
RESULTS: Out of the 100 samples analysed, 43% yielded pure cultures of bacterial isolates, 2% yielded mixed cultures while no bacterial growths were recorded from the remaining 55% samples. Organisms encountered were Staphylococcus aureus (16%), Escherichia coli (10%), Streptococcus faecalis (8%), Pseudomonas aeruginosa (4%), Streptococcus pyogenes (3%), Klebsiella pneumoniae (3%), Proteus rettgeri (2%) and Proteus mirabilis (1%). The highest percentage occurrence of pathogenic isolates was observed in polygamous married patients (90%). The age group most affected falls within the mean age 30.5 years (68%) while the least affected group falls within the mean age 40.5 years (5%). There was a significant difference in the acquisition of PID in relation to marital status (P < 0.05). However there was no significant difference in the acquisition of the disease with respect to age (P > 0.05). Antibiogram patterns of pathogenic isolates revealed varied resistance to most of the antibiotics employed. Cefotaxime (a new generation cephalosporin antibiotic) was established in this study as the best antimicrobial agent for treatment of PID due to Gram-positive and Gram-negative bacteria isolated from the women examined.
CONCLUSION: In conclusion, Pelvic inflammatory disease is a major health problem in developed or developing countries of the world. PID is not a notifiable disease, as accurate statistics on disease prevalence are rarely available. There is therefore no doubt thousands of young women have salpingitis every year and their sheer number makes it an important health problem. PID hence can be said to be a very serious complication of sexually transmitted disease which should be critically and promptly handled by healthcare providers. The right type sample should be aseptically collected and be appropriately handled for laboratory investigation. Treatment of PID should be initiated as soon as the presumptive diagnosis has been made. Immediate administration of antibiotics has been effective in the long-term sequelae associated with PID, especially new generation antibiotics, such as cefotaxime as recorded in this study.

Entities:  

Keywords:  Bacterial isolates; Female patients; Pelvic inflammatory disease

Year:  2014        PMID: 24653811      PMCID: PMC3957208          DOI: 10.4314/ajid.v8i1.3

Source DB:  PubMed          Journal:  Afr J Infect Dis        ISSN: 2006-0165


  4 in total

Review 1.  Pelvic inflammatory disease.

Authors:  Jonathan Ross
Journal:  Clin Evid       Date:  2002-06

2.  Pelvic inflammation induced by diagnostic laparoscopy in baboons.

Authors:  T M D'Hooghe; C S Bambra; B M Raeymaekers; J A Hill
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

3.  Pelvic inflammatory disease in HIV-positive women.

Authors:  R L Sweet; D V Landers
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

4.  Role of anaerobes in acute pelvic inflammatory disease.

Authors:  S Saini; N Gupta; G Batra; D R Arora
Journal:  Indian J Med Microbiol       Date:  2003 Jul-Sep       Impact factor: 0.985

  4 in total
  6 in total

1.  Can mean platelet volume be a novel predictive marker in patients with pelvic inflammatory disease?

Authors:  Ergenekon Karagöz
Journal:  Wien Klin Wochenschr       Date:  2014-09-13       Impact factor: 1.704

2.  Spontaneous Streptococcus pyogenes pelvic inflammatory disease; Case report and review of the literature.

Authors:  A Snyder; S A Schmalzle
Journal:  IDCases       Date:  2020-05-05

3.  Metabonomic study of the protective effect of Fukeqianjin formula on multi-pathogen induced pelvic inflammatory disease in rats.

Authors:  Yan Zhang; Wei Li; Liang Zou; Yun Gong; Peng Zhang; Shasha Xing; Hang Yang
Journal:  Chin Med       Date:  2018-12-10       Impact factor: 5.455

4.  Effect of Inonotus obliquus polysaccharide on composition of the intestinal flora in mice with acute endometritis.

Authors:  Binhong Hu; Yuqing Dong; Wenjing Zhou; Yichuan Ma; Luyao Li; Xianhua Fu; Wenxuan Zhang; Yuanyue Luo; Jingyu Pu; Xin Deng; Rong Zhang; Songqing Liu
Journal:  PLoS One       Date:  2021-11-05       Impact factor: 3.240

5.  How prevalent are symptoms and risk factors of pelvic inflammatory disease in a sexually conservative population.

Authors:  Oqba Al-Kuran; Lama Al-Mehaisen; Hamza Alduraidi; Naser Al-Husban; Balqees Attarakih; Anas Sultan; Zeina Othman; Sanal AlShárat; Shoug AlHilali; Nadia Alkouz; Noura Alibrahim; Wafaa AlMusallam
Journal:  Reprod Health       Date:  2021-05-28       Impact factor: 3.223

Review 6.  Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision.

Authors:  Vickram A S; Kuldeep Dhama; Sandip Chakraborty; Hari Abdul Samad; Shyma K Latheef; Khan Sharun; Sandip Kumar Khurana; Archana K; Ruchi Tiwari; Prakash Bhatt; Vyshali K; Wanpen Chaicumpa
Journal:  Vaccines (Basel)       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.